UniProt ID | CSPG4_RAT | |
---|---|---|
UniProt AC | Q00657 | |
Protein Name | Chondroitin sulfate proteoglycan 4 | |
Gene Name | Cspg4 | |
Organism | Rattus norvegicus (Rat). | |
Sequence Length | 2326 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein Extracellular side . Apical cell membrane Single-pass type I membrane protein Extracellular side . Cell projection, lamellipodium membrane Single-pass type I membrane protein Extracellular side |
|
Protein Description | Proteoglycan playing a role in cell proliferation and migration which stimulates endothelial cells motility during microvascular morphogenesis. May also inhibit neurite outgrowth and growth cone collapse during axon regeneration. Cell surface receptor for collagen alpha 2(VI) which may confer cells ability to migrate on that substrate. Binds through its extracellular N-terminus growth factors, extracellular matrix proteases modulating their activity. May regulate MPP16-dependent degradation and invasion of type I collagen participating in melanoma cells invasion properties. May modulate the plasminogen system by enhancing plasminogen activation and inhibiting angiostatin. Functions also as a signal transducing protein by binding through its cytoplasmic C-terminus scaffolding and signaling proteins. May promote retraction fiber formation and cell polarization through Rho GTPase activation. May stimulate alpha-4, beta-1 integrin-mediated adhesion and spreading by recruiting and activating a signaling cascade through CDC42, ACK1 and BCAR1. May activate FAK and ERK1/ERK2 signaling cascades.. | |
Protein Sequence | MLLSPGHPLSAPALALILTLALLVRSTAPASFFGENHLEVPVPSALTRVDLLLQFSTSQPEALLLLAAGQTDHLLLQLQSGHLQVRLALGQNELSLQTPADTVLSDSTTHTVVLTVSNSWAVLSVDGVLNTSAPIPKASHLKVPYGLFVGSSGSLDLPYLKGISRPLRGCLHSAILNGRNLLRPLTPDVHEGCAEEFSAGDEVGLGFSGPHSLAAFPAWSTREEGTLEFTLTTRSQQAPLAFQAGDKRGNFIYVDIFEGHLRAVVEKGQGTMLLRNSVPVADGQPHEVSVHIDVHRLEISVDQYPTRTFNRGVLSYLEPRGSLLLGGLDTEASRHLQEHRLGLTPGAANISLVGCIEDFSVNGRRLGLRDAWLTRDMAAGCRPEEDEYEEEVYGPFEAFSTLAPEAWPVMDLPEPCVPEPGLPAVFANFTQLLTISPLVVAEGGTAWLEWRHVQPTLDLTEAELRKSQVLFSVSQGARHGELELDIPGAQTRKMFTLLDVVNRKARFVHDGSEDTSDQLMLEVSVTSRAPVPSCLRRGQIYILPIQVNPVNDPPRIVFPHGSLMVILEHTQKPLGPEIFQAYDPDSACEGLTIQLLGVSASVPVEHRDQPGEPVTEFSCRDLEAGNIVYVHRGGPAQDLTFRVSDGMQASGPATLKVVAVRPAIQILHNTGLRLAQGSAAAILPANLSVETNAVGQDVSVLFRVTGTLQFGELQKQGAGGVEGTEWWDTLAFHQRDVEQGRVRYLSTDPQHHTQDTVEDLTLEVQVGQETLSNLSFPVTIQRATVWMLQLEPLHTQNPHQETLTSAHLEASLEEEGEGGPYPHIFHYELVQAPRRGNLLLQGTRLSDGQSFSQSDLQAGRVTYRATTRTSEAAEDSFRFRVTSPPHFSPLYTFPIHIGGDPNAPVLTNVLLMVPEGGEGVLSADHLFVKSLNSASYLYEVMEQPHHGSLAWRDPKGRATPVTSFTNEDLLHGRLVYQHDDSETIEDDIPFVATRQGEGSGDMAWEEVRGVFRVAIQPVNDHAPVQTISRVFHVARGGQRLLTTDDVAFSDADSGFSDAQLVLTRKDLLFGSIVAMEEPTRPIYRFTQEDLRKKQVLFVHSGADHGWLQLQVSDGQHQATAMLEVQASEPYLHVANSSSLVVPQGGQGTIDTAVLHLDTNLDIRSGNEVHYHVTAGPHWGQLLRDGQSVTSFSQRDLLDGAILYSHNGSLSPQDTLALSVAAGPVHTSTVLQVTIALEGPLAPLQLVQHKRIYVFQGEAAEIRRDQLEVVQEAVLPADIMFSLRSPPNAGYLVMVSHGASADGPPSLDPVQRFSQEAINSGRVLYLHSRPGAWSDSFSLDVASGLGDPLEGISVELEVLPTVIPLDVQNFSVPEGGTRTLAPPLIQITGPYLGTLPGLVLQVLEPPQHGALQKEDRPQDGTLSTFSWREVEEQLIRYVHDGSETQTDGFILLANASEMDRQSQPMAFTITILPVNDQPPVITTNTGLQIWEGAIVPIPPEALRGIDSDSGPEDLVYTIEQPSNGRIALRVAPDAEAHRFTQAQLDSGLVLFSHRGALEGGFHFDLSDGVHTSPGHFFRVVAQKQVLLSLEGSRKLTVCPESVQPLSSQSLSASSSTGSDPRHLLYQVVRGPQLGRLLHAQQGSAEEALVNFTQAEVNAGNILYEHEISSEPFWEAHDTIGLLLSSSPARDLAATLAVTVSFDAACPQRPSRLWRNKGLWVPEGQRAKITVAALDAANLLASVPASQRGRHDVLFQITQFPTRGQLLVSEEPLHARRPHFLQSELTAGQLVYAHGGGGTQQDGFRFRAHLQGPTGASVAGPQTSEAFVITVRDVNERPPQPQASIPLRITRGSRAPVSRAQLSVVDPDSAPGEIEYEVQRAPHNGFLSLAGDNTGPVTHFTQADVDAGRLAFVANGSSVAGVFQLSMSDGASPPIPMSLAVDVLPSTIEVQLRAPLEVPQALGRSSLSRQQLQVISDREEPDVAYRLTQGPLYGQVLVGGQPASAFSQLQVDQGDVVFAFTNFSSSQDHFKVLALARGVNASATVNVTVQALLHVWAGGPWPQGTTLRLDPTVLDASELANRTGSMPRFRLLEGPRYGRVVRVSQGRAESRTNQLVEDFTQQDLEEGRLGLEVGRPEGRSTGPTGDRLTLELQATGVPPAVALLDFATEPYHAAKFYKVTLLSVPEAARTETEKTGKSTPTGQPGQAASSPMPTVAKSGFLGFLEANMFSVIIPVCLVLLLLALILPLLFYLRKRNKTGKHDVQVLTAKPRNGLAGDTETFRKVEPGQAIPLTTVPGQGPPPGGQPDPELLQFCRTPNPALRNGQYWV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
130 | N-linked_Glycosylation | LSVDGVLNTSAPIPK EEECCEECCCCCCCC | 29.58 | - | |
349 | N-linked_Glycosylation | GLTPGAANISLVGCI CCCCCCCCEEEEEEE | 24.69 | - | |
428 | N-linked_Glycosylation | GLPAVFANFTQLLTI CCCCCCCCCCCCEEC | 29.09 | - | |
686 | N-linked_Glycosylation | AAAILPANLSVETNA EEEEEECCEEEECCC | 30.80 | - | |
773 | N-linked_Glycosylation | VGQETLSNLSFPVTI ECCCHHHCCCCCEEE | 42.70 | - | |
999 | O-linked_Glycosylation | ATRQGEGSGDMAWEE EEECCCCCCCCHHHH | 27.58 | 11493670 | |
1086 | Phosphorylation | TRPIYRFTQEDLRKK CCCCEECCHHHHHHC | 23.27 | 24259510 | |
1135 | N-linked_Glycosylation | EPYLHVANSSSLVVP CCEEEECCCCCEEEC | 41.14 | - | |
1189 | Phosphorylation | LRDGQSVTSFSQRDL CCCCCCCCCCHHHHC | 29.33 | 27097102 | |
1190 | Phosphorylation | RDGQSVTSFSQRDLL CCCCCCCCCHHHHCC | 22.27 | 27097102 | |
1192 | Phosphorylation | GQSVTSFSQRDLLDG CCCCCCCHHHHCCCC | 24.87 | 27097102 | |
1206 | N-linked_Glycosylation | GAILYSHNGSLSPQD CCEEEEECCCCCHHH | 35.49 | - | |
1368 | N-linked_Glycosylation | VIPLDVQNFSVPEGG EEECCCCCCCCCCCC | 30.89 | - | |
1453 | N-linked_Glycosylation | DGFILLANASEMDRQ CCEEEEEEHHHCCCC | 43.92 | - | |
1649 | N-linked_Glycosylation | SAEEALVNFTQAEVN CHHHHHHHHHHHHHH | 34.79 | - | |
1913 | N-linked_Glycosylation | GRLAFVANGSSVAGV CCEEEEECCCCEEEE | 45.65 | - | |
2020 | N-linked_Glycosylation | DVVFAFTNFSSSQDH CEEEEEECCCCCCCH | 28.48 | - | |
2038 | N-linked_Glycosylation | LALARGVNASATVNV HHHHCCCCCCCEECH | 30.88 | - | |
2044 | N-linked_Glycosylation | VNASATVNVTVQALL CCCCCEECHHHHHHH | 21.27 | - | |
2079 | N-linked_Glycosylation | LDASELANRTGSMPR ECHHHHHHHCCCCCC | 55.46 | - | |
2190 | Phosphorylation | PEAARTETEKTGKST CHHHCCCCCCCCCCC | 42.01 | 16641100 | |
2207 | Phosphorylation | GQPGQAASSPMPTVA CCCCCCCCCCCCCCH | 37.68 | 16641100 | |
2208 | Phosphorylation | QPGQAASSPMPTVAK CCCCCCCCCCCCCHH | 22.08 | 16641100 | |
2256 | Phosphorylation | YLRKRNKTGKHDVQV HHHHHCCCCCCCEEE | 55.82 | 17591920 | |
2265 | Phosphorylation | KHDVQVLTAKPRNGL CCCEEEEEECCCCCC | 33.50 | 17591920 | |
2314 | Phosphorylation | ELLQFCRTPNPALRN HHHHHHCCCCHHHCC | 28.71 | 17591920 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
2256 | T | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
2256 | T | Phosphorylation | Kinase | PRKCA | P05696 | Uniprot |
2265 | T | Phosphorylation | Kinase | MAPK1 | P63085 | GPS |
2314 | T | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
2314 | T | Phosphorylation | Kinase | ERK2 | P63085 | PSP |
2314 | T | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CSPG4_RAT !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CSPG4_RAT !! |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
O-linked Glycosylation | |
Reference | PubMed |
"Chondroitin sulfate and cytoplasmic domain-dependent membranetargeting of the NG2 proteoglycan promotes retraction fiber formationand cell polarization."; Stallcup W.B., Dahlin-Huppe K.; J. Cell Sci. 114:2315-2325(2001). Cited for: MUTAGENESIS OF SER-999 AND SER-1342, SUBCELLULAR LOCATION,GLYCOSYLATION AT SER-999, AND FUNCTION. | |
Phosphorylation | |
Reference | PubMed |
"Phosphorylation of NG2 proteoglycan by protein kinase C-alpharegulates polarized membrane distribution and cell motility."; Makagiansar I.T., Williams S., Dahlin-Huppe K., Fukushi J.,Mustelin T., Stallcup W.B.; J. Biol. Chem. 279:55262-55270(2004). Cited for: PHOSPHORYLATION AT THR-2256, INTERACTION WITH PRKCA, SUBCELLULARLOCATION, MUTAGENESIS OF THR-2256; THR-2265 AND THR-2278, ANDFUNCTION. |